Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.

Clinical trial NCT05142228 · TERMINATED

Trial details

NCT number: NCT05142228
Sponsor: University of Maryland, Baltimore
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Trigeminal Neuropathy

Start date: 2022-05-31
Primary completion: 2022-10-27
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.